CWG
C WorldWide Group Portfolio holdings
AUM
$7.38B
This Quarter Return
+4.48%
1 Year Return
+18.35%
3 Year Return
+71.53%
5 Year Return
+105.42%
10 Year Return
+360.65%
AUM
$7B
AUM Growth
+$7B
(+3.2%)
Cap. Flow
+$562M
Cap. Flow
% of AUM
8.02%
Top 10 Holdings %
Top 10 Hldgs %
60.82%
Holding
146
New
18
Increased
43
Reduced
34
Closed
13
Top Buys
| 1 |
Ecolab
ECL
|
$309M |
| 2 |
McKesson
MCK
|
$220M |
| 3 |
AbbVie
ABBV
|
$15.2M |
| 4 |
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
|
$14.9M |
| 5 |
CEMP
Cempra, Inc.
CEMP
|
$11.4M |
Top Sells
| 1 |
Microsoft
MSFT
|
$414M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
$21.2M |
| 3 |
Visa
V
|
$18.9M |
| 4 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$17.3M |
| 5 |
Gilead Sciences
GILD
|
$15.7M |
Sector Composition
| 1 | Financials | 32.87% |
| 2 | Healthcare | 23.56% |
| 3 | Communication Services | 16.37% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Materials | 7.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABMD
51
DELISTED
Abiomed Inc
ABMD
| $6.08M | 0.09% |
84,888
-20,000
| -19% | -$1.43M |
|
|
CPHD
52
DELISTED
Cepheid Inc
CPHD
| $5.97M | 0.09% |
105,000
+16,579
| +19% | +$943K |
|
|
EIGR
53
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $5.68M | 0.08% |
+300,000
| New | +$5.68M |
|
|
EGRX
54
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $5.63M | 0.08% |
134,407
+40,000
| +42% | +$1.68M |
|
|
WCG
55
DELISTED
Wellcare Health Plans, Inc.
WCG
| $5.03M | 0.07% |
55,000
+13,045
| +31% | +$1.19M |
|
|
LDRH
56
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $5.02M | 0.07% |
136,917
+60,000
| +78% | +$2.2M |
|
57
DexCom
DXCM
$30.9B
| $4.98M | 0.07% |
79,925
+10,000
| +14% | +$623K |
|
58
Exact Sciences
EXAS
$9.33B
| $4.84M | 0.07% |
+220,000
| New | +$4.84M |
|
|
NUVA
59
DELISTED
NuVasive, Inc.
NUVA
| $4.74M | 0.07% |
103,160
+40,000
| +63% | +$1.84M |
|
|
CERN
60
DELISTED
Cerner Corp
CERN
| $4.69M | 0.07% |
63,978
-57,000
| -47% | -$4.18M |
|
61
Supernus Pharmaceuticals
SUPN
$2.52B
| $4.59M | 0.07% |
380,000
+250,000
| +192% | +$3.02M |
|
|
EXAM
62
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
| $4.37M | 0.06% |
104,925
+35,000
| +50% | +$1.46M |
|
|
RLYP
63
DELISTED
RELYPSA INC COM
RLYP
| $4.33M | 0.06% |
+120,000
| New | +$4.33M |
|
|
SPNC
64
DELISTED
Spectranetics Corp
SPNC
| $4.31M | 0.06% |
123,956
| – | – |
|
65
MiMedx Group
MDXG
$1.05B
| $4.16M | 0.06% |
400,000
+200,000
| +100% | +$2.08M |
|
|
KYTH
66
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
| $4.09M | 0.06% |
81,517
-12,500
| -13% | -$627K |
|
67
TSMC
TSM
$1.2T
| $4.04M | 0.06% |
172,060
+159,910
| +1,316% | +$3.75M |
|
|
ATHN
68
DELISTED
Athenahealth, Inc.
ATHN
| $3.73M | 0.05% |
31,222
+5,000
| +19% | +$597K |
|
69
Acadia Healthcare
ACHC
$2.15B
| $3.58M | 0.05% |
+50,000
| New | +$3.58M |
|
|
SRNE
70
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $3.03M | 0.04% |
262,301
-10,000
| -4% | -$116K |
|
71
Acadia Pharmaceuticals
ACAD
$4.34B
| $2.93M | 0.04% |
89,925
-5,000
| -5% | -$163K |
|
|
ONCE
72
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $2.87M | 0.04% |
+37,000
| New | +$2.87M |
|
|
AERI
73
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $2.85M | 0.04% |
90,903
| – | – |
|
74
Dynavax Technologies
DVAX
$1.19B
| $2.8M | 0.04% |
124,962
+90,000
| +257% | +$2.02M |
|
|
TVRD
75
Tvardi Therapeutics, Inc. Common Stock
TVRD
$270M
| $2.8M | 0.04% |
278,841
+67,000
| +32% | +$674K |
|